|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/24/22 Can-Fite BioPharma Ltd. 20-F 12/31/21 74:7.3M EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size
1: 20-F Annual Report HTML 1.38M
2: EX-8.1 List of Subsidiaries of Can-Fite Biopharma Ltd HTML 20K
5: EX-13.1 Certification Exhibit HTML 22K
6: EX-13.2 Certification Exhibit HTML 22K
3: EX-12.1 Certification Exhibit HTML 26K
4: EX-12.2 Certification Exhibit HTML 26K
7: EX-15.1 Consent of Independent Registered Public HTML 23K
Accounting Firm
13: R1 Document And Entity Information HTML 99K
14: R2 Consolidated Balance Sheets HTML 125K
15: R3 Consolidated Balance Sheets (Parentheticals) HTML 30K
16: R4 Consolidated Statements of Comprehensive Loss HTML 78K
17: R5 Consolidated Statements of Changes in Equity HTML 70K
18: R6 Consolidated Statements of Changes in Equity HTML 25K
(Parentheticals)
19: R7 Consolidated Statements of Cash Flows HTML 98K
20: R8 General HTML 27K
21: R9 Significant Accounting Policies HTML 74K
22: R10 Other Accounts Receivable and Prepaid Expenses HTML 26K
23: R11 Short-Term Investment HTML 24K
24: R12 Property, Plant and Equipment, Net HTML 31K
25: R13 Other Accounts Payable HTML 26K
26: R14 Fair Value Measurements HTML 34K
27: R15 Contingent Liabilities and Commitments HTML 43K
28: R16 Shareholders' Equity HTML 58K
29: R17 Share-Based Payment Transactions HTML 49K
30: R18 Leases HTML 32K
31: R19 Finance Income (Expense) HTML 33K
32: R20 Taxes on Income HTML 34K
33: R21 Transactions with Related Parties HTML 25K
34: R22 Accounting Policies, by Policy (Policies) HTML 128K
35: R23 Significant Accounting Policies (Tables) HTML 30K
36: R24 Other Accounts Receivable and Prepaid Expenses HTML 26K
(Tables)
37: R25 Property, Plant and Equipment, Net (Tables) HTML 30K
38: R26 Other Accounts Payable (Tables) HTML 26K
39: R27 Fair Value Measurements (Tables) HTML 32K
40: R28 Shareholders' Equity (Tables) HTML 28K
41: R29 Share-Based Payment Transactions (Tables) HTML 50K
42: R30 Leases (Tables) HTML 33K
43: R31 Finance Income (Expense) (Tables) HTML 33K
44: R32 Taxes on Income (Tables) HTML 27K
45: R33 General (Details) HTML 37K
46: R34 Significant Accounting Policies (Details) HTML 36K
47: R35 Significant Accounting Policies (Details) - HTML 31K
Schedule of property, plant and equipment
48: R36 Significant Accounting Policies (Details) - HTML 32K
Schedule of major customer data as a percentage of
total revenues
49: R37 Other Accounts Receivable and Prepaid Expenses HTML 26K
(Details) - Schedule of other accounts receivable
and prepaid expenses
50: R38 Short-Term Investment (Details) HTML 24K
51: R39 Property, Plant and Equipment, Net (Details) HTML 24K
52: R40 Property, Plant and Equipment, Net (Details) - HTML 40K
Schedule of property, plant and equipment, net
53: R41 Other Accounts Payable (Details) - Schedule of HTML 27K
other accounts payable
54: R42 Fair Value Measurements (Details) - Schedule of HTML 33K
financial assets and liabilities measured at fair
value on a recurring basis
55: R43 Contingent Liabilities and Commitments (Details) HTML 87K
56: R44 Shareholders' Equity (Details) HTML 162K
57: R45 Shareholders' Equity (Details) - Schedule of HTML 56K
information regarding outstanding warrants to
purchase shares
58: R46 Share-Based Payment Transactions (Details) HTML 46K
59: R47 Share-Based Payment Transactions (Details) - HTML 28K
Schedule of expenses
60: R48 Share-Based Payment Transactions (Details) - HTML 42K
Schedule of estimated using the binomial option
pricing model
61: R49 Share-Based Payment Transactions (Details) - HTML 39K
Schedule of weighted average exercise prices and
modification in option plans of employees
62: R50 Share-Based Payment Transactions (Details) - HTML 56K
Schedule of options outstanding classified by
exercise price
63: R51 Leases (Details) HTML 23K
64: R52 Leases (Details) - Schedule of lease expense and HTML 35K
supplemental cash flow information related to
leases and weighted average remaining lease terms
and discount rate
65: R53 Leases (Details) - Schedule of maturities of lease HTML 33K
liabilities
66: R54 Finance Income (Expense) (Details) - Schedule of HTML 43K
components of finance (Income)
67: R55 Taxes on Income (Details) HTML 27K
68: R56 Taxes on Income (Details) - Schedule of deferred HTML 32K
tax assets and liabilities
69: R57 Transactions with Related Parties (Details) HTML 23K
72: XML IDEA XML File -- Filing Summary XML 134K
70: XML XBRL Instance -- f20f2021_canfitebio_htm XML 933K
71: EXCEL IDEA Workbook of Financial Reports XLSX 88K
9: EX-101.CAL XBRL Calculations -- canf-20211231_cal XML 84K
10: EX-101.DEF XBRL Definitions -- canf-20211231_def XML 586K
11: EX-101.LAB XBRL Labels -- canf-20211231_lab XML 1.17M
12: EX-101.PRE XBRL Presentations -- canf-20211231_pre XML 585K
8: EX-101.SCH XBRL Schema -- canf-20211231 XSD 189K
73: JSON XBRL Instance as JSON Data -- MetaLinks 291± 401K
74: ZIP XBRL Zipped Folder -- 0001213900-22-014672-xbrl Zip 830K
Exhibit 8.1
Subsidiary of Can-Fite BioPharma Ltd.
The following table sets forth the name and jurisdiction of incorporation of our subsidiary.
| Name of Subsidiary | Jurisdiction of Incorporation | |
| Can-Fite Biopharma Europe | France |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/05/24 Can-Fite BioPharma Ltd. POS AM 2:512K EdgarAgents LLC/FA 3/28/24 Can-Fite BioPharma Ltd. 20-F 12/31/23 77:6.9M EdgarAgents LLC/FA 3/30/23 Can-Fite BioPharma Ltd. 20-F 12/31/22 79:7.8M EdgarAgents LLC/FA 1/13/23 Can-Fite BioPharma Ltd. 424B5 1:486K EdgarAgents LLC/FA 8/26/22 Can-Fite BioPharma Ltd. POS AM 2:657K EdgarAgents LLC/FA 3/25/22 Can-Fite BioPharma Ltd. POS AM 2:772K EdgarAgents LLC/FA |